Xtx Topco LTD Vericel Corp Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$41.71 - $52.9 $92,971 - $117,914
2,229 Added 36.93%
8,265 $379,000
Q1 2024

May 13, 2024
BUY
$32.52 - $52.33 $196,290 - $315,863
6,036 New
6,036 $313,000
Q3 2023

Nov 13, 2023
BUY
$31.69 - $39.25 $221,671 - $274,553
6,995 Added 68.81%
17,161 $575,000
Q2 2023

Aug 14, 2023
BUY
$29.0 - $38.37 $294,814 - $390,069
10,166 New
10,166 $381,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.5M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.61B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email